<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36527565</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-6814</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cell and tissue banking</Title><ISOAbbreviation>Cell Tissue Bank</ISOAbbreviation></Journal><ArticleTitle>Regenerative medicine improve neurodegenerative diseases.</ArticleTitle><Pagination><StartPage>639</StartPage><EndPage>650</EndPage><MedlinePgn>639-650</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10561-022-10062-0</ELocationID><Abstract><AbstractText>Regenerative medicine is a subdivision of medicine that improves methods to regrow, repair or replace unhealthy cells and tissues to return to normal function. Cell therapy, gene therapy, nanomedicine as choices used to cure neurodegenerative disease. Recently, studies related to the treatment of neurodegenerative disorders have been focused on stem cell therapy and Nano-drugs beyond other than regenerative medicine. Hence, by data from experimental models and clinical trials, we review the impact of stem cell therapy, gene therapy, and nanomedicine on the treatment of Alzheimer's disease (AD), Parkinson's disease (PD), and Amyotrophic lateral sclerosis (ALS). Indeed, improved knowledge and continued research on gene therapy and nanomedicine in treating Alzheimer's disease, Parkinson's disease, and Amyotrophic lateral sclerosis lead to advancements in effective and practical treatments for neurodegenerative diseases.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ashraf</LastName><ForeName>Seyedeh Sara</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institutes of Regenerative Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hosseinpour Sarmadi</LastName><ForeName>Vahid</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institutes of Regenerative Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larijani</LastName><ForeName>Ghazaleh</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naderi Garahgheshlagh</LastName><ForeName>Soheila</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Burn Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Plastic and Reconstructive surgery, Hazrat Fatemeh Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramezani</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroscience Research Center, Guilan Road Trauma Research Center, Guilan University of Medical Sciences, Rasht, Guilan, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Guilan Road Trauma Research Center, Guilan University of Medical Sciences, Rasht, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moghadamifar</LastName><ForeName>Soraya</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Textile Engineering, Amirkabir University of Technology, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohebi</LastName><ForeName>Seyedeh Lena</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institutes of Regenerative Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brouki Milan</LastName><ForeName>Peiman</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institutes of Regenerative Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haramshahi</LastName><ForeName>Seyed Mohammad Amin</ForeName><Initials>SMA</Initials><AffiliationInfo><Affiliation>Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Plastic and Reconstructive surgery, Hazrat Fatemeh Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmadirad</LastName><ForeName>Nooshin</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-9853-8180</Identifier><AffiliationInfo><Affiliation>Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran. ahmadiyerad@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amini</LastName><ForeName>Naser</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran, Iran. amini_ot@yahoo.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institutes of Regenerative Medicine, Iran University of Medical Sciences, Tehran, Iran. amini_ot@yahoo.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Cell Tissue Bank</MedlineTA><NlmUniqueID>100965121</NlmUniqueID><ISSNLinking>1389-9333</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044968" MajorTopicYN="N">Regenerative Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cell therapy</Keyword><Keyword MajorTopicYN="N">Engineered nanoparticles</Keyword><Keyword MajorTopicYN="N">Gene therapy</Keyword><Keyword MajorTopicYN="N">Neurodegenerative disorders</Keyword><Keyword MajorTopicYN="N">Regenerative medicine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>31</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>17</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36527565</ArticleId><ArticleId IdType="doi">10.1007/s10561-022-10062-0</ArticleId><ArticleId IdType="pii">10.1007/s10561-022-10062-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aderibigbe BA (2017) Metal-based nanoparticles for the treatment of infectious diseases. Molecules 22(8):1370</Citation><ArticleIdList><ArticleId IdType="pubmed">28820471</ArticleId><ArticleId IdType="pmc">6152252</ArticleId></ArticleIdList></Reference><Reference><Citation>Alam M, Abbas K (2021) An insight into neurodegenerative disorders, their therapeutic approaches and drugs available for tackling with neurodegeneration: a review. IAR J Med Case Rep 2(3):1</Citation></Reference><Reference><Citation>Alipour M et al (2019) Stem cell therapy in Alzheimer&#x2019;s disease: possible benefits and limiting drawbacks. Mol Biol Rep 46(1):1425&#x2013;1446</Citation><ArticleIdList><ArticleId IdType="pubmed">30565076</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves S et al (2017) Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer&#x2019;s disease mice. Brain 140(3):826&#x2013;842</Citation><ArticleIdList><ArticleId IdType="pubmed">28003243</ArticleId></ArticleIdList></Reference><Reference><Citation>Amini N et al (2016) Efficacy of human adipose tissue-derived stem cells on neonatal bilirubin encephalopathy in rats. Neurotox Res 29(4):514&#x2013;524</Citation><ArticleIdList><ArticleId IdType="pubmed">26818600</ArticleId></ArticleIdList></Reference><Reference><Citation>Amini N et al (2019) Transplantation of adipose tissue-derived stem cells into brain through cerebrospinal fluid in rat models: protocol development and initial outcome data. Curr Stem Cell Res Ther 14(2):191&#x2013;195</Citation><ArticleIdList><ArticleId IdType="pubmed">30027854</ArticleId></ArticleIdList></Reference><Reference><Citation>Atala A (2004) Tissue engineering and regenerative medicine: concepts for clinical application. Rejuvenation Res 7(1):15&#x2013;31</Citation><ArticleIdList><ArticleId IdType="pubmed">15256042</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz M et al (2004) VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429(6990):413&#x2013;417</Citation><ArticleIdList><ArticleId IdType="pubmed">15164063</ArticleId></ArticleIdList></Reference><Reference><Citation>Babahajian A et al (2019) Neuroprotective effects of trolox, human chorionic gonadotropin, and carnosic acid on hippocampal neurodegeneration after ischemia-reperfusion injury. Curr Stem Cell Res Ther 14(2):177&#x2013;183</Citation><ArticleIdList><ArticleId IdType="pubmed">30227824</ArticleId></ArticleIdList></Reference><Reference><Citation>Bangde P et al (2017) Potential gene therapy towards treating neurodegenerative disea ses employing polymeric nanosystems. Curr Gene Ther 17(2):170&#x2013;183</Citation><ArticleIdList><ArticleId IdType="pubmed">28494742</ArticleId></ArticleIdList></Reference><Reference><Citation>Biferi MG et al (2017) A new AAV10-U7-mediated gene therapy prolongs survival and restores function in an ALS mouse model. Mol Ther 25(9):2038&#x2013;2052</Citation><ArticleIdList><ArticleId IdType="pubmed">28663100</ArticleId><ArticleId IdType="pmc">5589057</ArticleId></ArticleIdList></Reference><Reference><Citation>Bj&#xf6;rklund A, Lindvall O (2000) Cell replacement therapies for central nervous system disorders. Nat Neurosci 3(6):537&#x2013;544</Citation><ArticleIdList><ArticleId IdType="pubmed">10816308</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR et al (2000) El escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(5):293&#x2013;299</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T et al (2017) Small-sized mPEG&#x2013;PLGA nanoparticles of schisantherin a with sustained release for enhanced brain uptake and anti-parkinsonian activity. ACS Appl Mater Interfaces 9(11):9516&#x2013;9527</Citation><ArticleIdList><ArticleId IdType="pubmed">28247754</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W et al (2018) Black phosphorus nanosheets as a neuroprotective nanomedicine for neurodegenerative disorder therapy. Adv Mater 30(3):1703458</Citation></Reference><Reference><Citation>Chowdhury SR et al (2016) Modulation of amyloid aggregates into nontoxic coaggregates by hydroxyquinoline appended polyfluorene. ACS Appl Mater Interface 8(21):13309&#x2013;13319</Citation></Reference><Reference><Citation>Colonna M, Butovsky O (2017) Microglia function in the central nervous system during health and neurodegeneration. Annu Rev Immunol 35:441&#x2013;468</Citation><ArticleIdList><ArticleId IdType="pubmed">28226226</ArticleId><ArticleId IdType="pmc">8167938</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornejo F, von Bernhardi R (2016) Age-dependent changes in the activation and regulation of microglia. Gl Cell Health Disease CNS. 1:205</Citation></Reference><Reference><Citation>Cummings J, Fox N (2017) Defining disease modifying therapy for Alzheimer&#x2019;s disease. J Prev Alzheimers Dis 4(2):109&#x2013;115</Citation><ArticleIdList><ArticleId IdType="pubmed">29071250</ArticleId><ArticleId IdType="pmc">5653310</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings J et al (2017) Alzheimer&#x2019;s disease drug development pipeline: 2017. Alzheimer&#x2019;s Dement Trans Res Clin Interv 3(3):367&#x2013;384</Citation></Reference><Reference><Citation>Dong X (2018) Current strategies for brain drug delivery. Theranostics 8(6):1481&#x2013;1493</Citation><ArticleIdList><ArticleId IdType="pubmed">29556336</ArticleId><ArticleId IdType="pmc">5858162</ArticleId></ArticleIdList></Reference><Reference><Citation>El Andaloussi S et al (2013) Exosomes for targeted siRNA delivery across biological barriers. Adv Drug Deliv Rev 65(3):391&#x2013;397</Citation><ArticleIdList><ArticleId IdType="pubmed">22921840</ArticleId></ArticleIdList></Reference><Reference><Citation>Emborg M et al (2009) Response of aged parkinsonian monkeys to in vivo gene transfer of GDNF. Neurobiol Dis 36(2):303&#x2013;311</Citation><ArticleIdList><ArticleId IdType="pubmed">19660547</ArticleId><ArticleId IdType="pmc">2989601</ArticleId></ArticleIdList></Reference><Reference><Citation>Enciu AM et al (2011) Neuroregeneration in neurodegenerative disorders. BMC Neurol 11(1):1&#x2013;7</Citation></Reference><Reference><Citation>Garbuzova-Davis S et al (2002) Positive effect of transplantation of hNT neurons (NTera 2/D1 Cell-Line) in a model of familial amyotrophic lateral sclerosis-volume 174, number 2 (2002) pages 169-180. Exp Neurol 2(175):451</Citation></Reference><Reference><Citation>Hagell P et al (1999) Sequential bilateral transplantation in Parkinson&#x2019;s disease: effects of the second graft. Brain 122(6):1121&#x2013;1132</Citation><ArticleIdList><ArticleId IdType="pubmed">10356064</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer&#x2019;s disease: progress and problems on the road to therapeutics. Science 297(5580):353&#x2013;356</Citation><ArticleIdList><ArticleId IdType="pubmed">12130773</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper JM et al (2004) Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats. Proc Natl Acad Sci 101(18):7123&#x2013;7128</Citation><ArticleIdList><ArticleId IdType="pubmed">15118094</ArticleId><ArticleId IdType="pmc">406476</ArticleId></ArticleIdList></Reference><Reference><Citation>Herzog CD et al (2013) Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120). Neurobiol Dis 58:38&#x2013;48</Citation><ArticleIdList><ArticleId IdType="pubmed">23631873</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunsberger JG et al (2016) Accelerating stem cell trials for Alzheimer&#x2019;s disease. Lancet Neurol 15(2):219&#x2013;230</Citation><ArticleIdList><ArticleId IdType="pubmed">26704439</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang D et al (2009) Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice. Gene Ther 16(10):1234&#x2013;1244</Citation><ArticleIdList><ArticleId IdType="pubmed">19626053</ArticleId></ArticleIdList></Reference><Reference><Citation>Jankovic J, Aguilar LG (2008) Current approaches to the treatment of Parkinson&#x2019;s disease. Neuropsychiatr Dis Treat 4(4):743&#x2013;757</Citation><ArticleIdList><ArticleId IdType="pubmed">19043519</ArticleId><ArticleId IdType="pmc">2536542</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr DA et al (2003) Human embryonic germ cell derivatives facilitate motor recovery of rats with diffuse motor neuron injury. J Neurosci 23(12):5131&#x2013;5140</Citation><ArticleIdList><ArticleId IdType="pubmed">12832537</ArticleId><ArticleId IdType="pmc">6741166</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC et al (2011) Amyotrophic lateral sclerosis. Lancet 377(9769):942&#x2013;955</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SU, De Vellis J (2009) Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res 87(10):2183&#x2013;2200</Citation><ArticleIdList><ArticleId IdType="pubmed">19301431</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiyota T et al (2015) AAV2/1 CD74 gene transfer reduces &#x3b2;-amyloidosis and improves learning and memory in a mouse model of Alzheimer&#x2019;s disease. Mol Ther 23(11):1712&#x2013;1721</Citation><ArticleIdList><ArticleId IdType="pubmed">26227349</ArticleId><ArticleId IdType="pmc">4817947</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima R et al (2018) Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson&#x2019;s disease treatment. Nat Commun 9(1):1305</Citation><ArticleIdList><ArticleId IdType="pubmed">29610454</ArticleId><ArticleId IdType="pmc">5880805</ArticleId></ArticleIdList></Reference><Reference><Citation>Korecka JA et al (2017) Repulsive guidance molecule a (RGMa) induces neuropathological and behavioral changes that closely resemble Parkinson&#x2019;s disease. J Neurosci 37(39):9361&#x2013;9379</Citation><ArticleIdList><ArticleId IdType="pubmed">28842419</ArticleId><ArticleId IdType="pmc">6596765</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotterman MA, Chalberg TW, Schaffer DV (2015) Viral vectors for gene therapy: translational and clinical outlook. Annu Rev Biomed Eng 17:63&#x2013;89</Citation><ArticleIdList><ArticleId IdType="pubmed">26643018</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee HJ et al (2007) Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PLoS ONE 2(1):e156</Citation><ArticleIdList><ArticleId IdType="pubmed">17225860</ArticleId><ArticleId IdType="pmc">1764718</ArticleId></ArticleIdList></Reference><Reference><Citation>LeWitt PA, Giladi N, Navon N (2019) Pharmacokinetics and efficacy of a novel formulation of carbidopa-levodopa (Accordion Pill&#xae;) in Parkinson&#x2019;s disease. Parkinsonism Relat Disord 65:131&#x2013;138</Citation><ArticleIdList><ArticleId IdType="pubmed">31176632</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D et al (2017) Slow intrathecal injection of rAAVrh10 enhances its transduction of spinal cord and therapeutic efficacy in a mutant SOD1 model of ALS. Neuroscience 365:192&#x2013;205</Citation><ArticleIdList><ArticleId IdType="pubmed">29024785</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindvall O, Kokaia Z (2010) Stem cells in human neurodegenerative disorders&#x2014;time for clinical translation? J Clin Investig 120(1):29&#x2013;40</Citation><ArticleIdList><ArticleId IdType="pubmed">20051634</ArticleId><ArticleId IdType="pmc">2798697</ArticleId></ArticleIdList></Reference><Reference><Citation>Maney V, Singh M (2017) An in vitro assessment of novel chitosan/bimetallic PtAu nanocomposites as delivery vehicles for doxorubicin. Nanomedicine 12(21):2625&#x2013;2640</Citation><ArticleIdList><ArticleId IdType="pubmed">28965478</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin JB (1999) Molecular basis of the neurodegenerative disorders. N Engl J Med 340(25):1970&#x2013;1980</Citation><ArticleIdList><ArticleId IdType="pubmed">10379022</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazibuko Z et al (2015) A review of the potential role of nano-enabled drug delivery technologies in amyotrophic lateral sclerosis: lessons learned from other neurodegenerative disorders. J Pharm Sci 104(4):1213&#x2013;1229</Citation><ArticleIdList><ArticleId IdType="pubmed">25559087</ArticleId></ArticleIdList></Reference><Reference><Citation>Miles GB et al (2004) Functional properties of motoneurons derived from mouse embryonic stem cells. J Neurosci 24(36):7848&#x2013;7858</Citation><ArticleIdList><ArticleId IdType="pubmed">15356197</ArticleId><ArticleId IdType="pmc">6729934</ArticleId></ArticleIdList></Reference><Reference><Citation>Morizane A (2019) Cell therapy for Parkinson&#x2019;s disease with induced pluripotent stem cells. Rinsho Shinkeigaku Clin Neurol 59(3):119&#x2013;124</Citation></Reference><Reference><Citation>Murlidharan G, Samulski RJ, Asokan A (2014) Biology of adeno-associated viral vectors in the central nervous system. Front Mol Neurosci 7:76</Citation><ArticleIdList><ArticleId IdType="pubmed">25285067</ArticleId><ArticleId IdType="pmc">4168676</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor DM, Boulis NM (2015) Gene therapy for neurodegenerative diseases. Trends Mol Med 21(8):504&#x2013;512</Citation><ArticleIdList><ArticleId IdType="pubmed">26122838</ArticleId></ArticleIdList></Reference><Reference><Citation>Onyango IG (2018) Modulation of mitochondrial bioenergetics as a therapeutic strategy in Alzheimer&#x2019;s disease. Neural Regen Res 13(1):19</Citation><ArticleIdList><ArticleId IdType="pubmed">29451200</ArticleId><ArticleId IdType="pmc">5840984</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortolano S, Spuch C, Navarro C (2012) Present and future of adeno associated virus based gene therapy approaches. Recent Pat Endocr Metab Immune Drug Discove 6(1):47&#x2013;66</Citation></Reference><Reference><Citation>Pahuja R et al (2015) Trans-blood brain barrier delivery of dopamine-loaded nanoparticles reverses functional deficits in parkinsonian rats. ACS Nano 9(5):4850&#x2013;4871</Citation><ArticleIdList><ArticleId IdType="pubmed">25825926</ArticleId></ArticleIdList></Reference><Reference><Citation>Piguet F, Alves S, Cartier N (2017) Clinical gene therapy for neurodegenerative diseases: past, present, and future. Hum Gene Ther 28(11):988&#x2013;1003</Citation><ArticleIdList><ArticleId IdType="pubmed">29035118</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillay S et al (2016) An essential receptor for adeno-associated virus infection. Nature 530(7588):108&#x2013;112</Citation><ArticleIdList><ArticleId IdType="pubmed">26814968</ArticleId><ArticleId IdType="pmc">4962915</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisati F et al (2007) Induction of neurotrophin expression via human adult mesenchymal stem cells: implication for cell therapy in neurodegenerative diseases. Cell Transplant 16(1):41&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">17436854</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu Y et al (2019) Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseases. Neural Regen Res 14(6):931</Citation><ArticleIdList><ArticleId IdType="pubmed">30761996</ArticleId><ArticleId IdType="pmc">6404499</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafii MS et al (2014) A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer&#x2019;s disease. Alzheimers Dement 10(5):571&#x2013;581</Citation><ArticleIdList><ArticleId IdType="pubmed">24411134</ArticleId></ArticleIdList></Reference><Reference><Citation>Raikwar SP et al (2019) Targeted gene editing of glia maturation factor in microglia: a novel Alzheimer&#x2019;s disease therapeutic target. Mol Neurobiol 56(1):378&#x2013;393</Citation><ArticleIdList><ArticleId IdType="pubmed">29704201</ArticleId></ArticleIdList></Reference><Reference><Citation>MS Rao, A Khanna, S Shin, (2008) Stem cells for the treatment of neurological disorders. CNS Neurol Disord-Drug Targ (Former Curr Drug Targ-CNS Neurol Disord), 7(1): p. 98-109</Citation></Reference><Reference><Citation>Rapti K et al (2012) Neutralizing antibodies against AAV serotypes 1, 2, 6, and 9 in sera of commonly used animal models. Mol Ther 20(1):73&#x2013;83</Citation><ArticleIdList><ArticleId IdType="pubmed">21915102</ArticleId></ArticleIdList></Reference><Reference><Citation>Redmond DE et al (2007) Behavioral improvement in a primate Parkinson&#x2019;s model is associated with multiple homeostatic effects of human neural stem cells. Proc Natl Acad Sci 104(29):12175&#x2013;12180</Citation><ArticleIdList><ArticleId IdType="pubmed">17586681</ArticleId><ArticleId IdType="pmc">1896134</ArticleId></ArticleIdList></Reference><Reference><Citation>Ristow M (2004) Neurodegenerative disorders associated with diabetes mellitus. J Mol Med 82(8):510&#x2013;529</Citation><ArticleIdList><ArticleId IdType="pubmed">15175861</ArticleId></ArticleIdList></Reference><Reference><Citation>Saadoun D et al (2011) Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med 365(22):2067&#x2013;2077</Citation><ArticleIdList><ArticleId IdType="pubmed">22129253</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahni JK et al (2011) Neurotherapeutic applications of nanoparticles in Alzheimer&#x2019;s disease. J Control Release 152(2):208&#x2013;231</Citation><ArticleIdList><ArticleId IdType="pubmed">21134407</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakthiswary R, Raymond AA (2012) Stem cell therapy in neurodegenerative diseases: from principles to practice. Neural Regen Res 7(23):1822</Citation><ArticleIdList><ArticleId IdType="pubmed">25624807</ArticleId><ArticleId IdType="pmc">4302533</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanooghi D et al (2021) Differentiation of mesenchymal stem cells derived from human adipose tissue into cholinergic-like cells: an in vitro study. Basic Clin Neurosci 12(3):315</Citation><ArticleIdList><ArticleId IdType="pubmed">34917291</ArticleId><ArticleId IdType="pmc">8666926</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasmita AO (2019) Current viral-mediated gene transfer research for treatment of Alzheimer&#x2019;s disease. Biotechnol Genet Eng Rev 35(1):26&#x2013;45</Citation><ArticleIdList><ArticleId IdType="pubmed">30317930</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamatovic SM, Keep RF, Andjelkovic AV (2008) Brain endothelial cell-cell junctions: how to &#x201c;open&#x201d; the blood brain barrier. Curr Neuropharmacol 6(3):179&#x2013;192</Citation><ArticleIdList><ArticleId IdType="pubmed">19506719</ArticleId><ArticleId IdType="pmc">2687937</ArticleId></ArticleIdList></Reference><Reference><Citation>Takagi Y et al (2005) Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Investig 115(1):102&#x2013;109</Citation><ArticleIdList><ArticleId IdType="pubmed">15630449</ArticleId><ArticleId IdType="pmc">539189</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong BC-K et al (1865) (2018) Calcium signaling in Alzheimer&#x2019;s disease &amp; therapies. Biochimica Et Biophysica Acta (BBA)-Mol Cell Res. 11:1745</Citation></Reference><Reference><Citation>Venkatas J, Singh M (2021) Nanomedicine-mediated optimization of immunotherapeutic approaches in cervical cancer. Nanomedicine 16(15):1311&#x2013;1328</Citation><ArticleIdList><ArticleId IdType="pubmed">34027672</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M-M et al (2018) Innate immune activation in Alzheimer&#x2019;s disease. Ann Trans Med 6(10):1</Citation></Reference><Reference><Citation>Watabe K et al (2000) Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line-derived neurotrophic factor. J Neurosci Res 60(4):511&#x2013;519</Citation><ArticleIdList><ArticleId IdType="pubmed">10797554</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L et al (2006) Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation 82(7):865&#x2013;875</Citation><ArticleIdList><ArticleId IdType="pubmed">17038899</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang JA et al (2014) &#x3b1;-Synuclein&#x2019;s adsorption, conformation, and orientation on cationic gold nanoparticle surfaces seeds global conformation change. J Phys Chem B 118(13):3559&#x2013;3571</Citation><ArticleIdList><ArticleId IdType="pubmed">24635210</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaqoob SB et al (2020) Gold, silver, and palladium nanoparticles: a chemical tool for biomedical applications. Front Chem 8:376</Citation><ArticleIdList><ArticleId IdType="pubmed">32582621</ArticleId><ArticleId IdType="pmc">7283583</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuhara T et al (2006) Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson&#x2019;s disease. J Neurosci 26(48):12497&#x2013;12511</Citation><ArticleIdList><ArticleId IdType="pubmed">17135412</ArticleId><ArticleId IdType="pmc">6674904</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L et al (2014) A non-invasive, rapid method to genotype late-onset Alzheimer&#x2019;s disease-related apolipoprotein E gene polymorphisms. Neural Regen Res 9(1):69</Citation><ArticleIdList><ArticleId IdType="pubmed">25206745</ArticleId><ArticleId IdType="pmc">4146311</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin H et al (2014) Non-viral vectors for gene-based therapy. Nat Rev Genet 15(8):541&#x2013;555</Citation><ArticleIdList><ArticleId IdType="pubmed">25022906</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N et al (2018) Localized delivery of curcumin into brain with polysorbate 80-modified cerasomes by ultrasound-targeted microbubble destruction for improved Parkinson&#x2019;s disease therapy. Theranostics 8(8):2264</Citation><ArticleIdList><ArticleId IdType="pubmed">29721078</ArticleId><ArticleId IdType="pmc">5928888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao L et al (2016) Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer&#x2019;s disease mouse models. Neurobiol Aging 44:159&#x2013;172</Citation><ArticleIdList><ArticleId IdType="pubmed">27318144</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabanov A, Gendelman HE (2007) Nanomedicine in the diagnosis and therapy of neurodegenerative disorders." Progress in Polymer Science 32(8&#x2013;9):1054&#x2013;1082</Citation></Reference><Reference><Citation>Lunn JS, Sakowski SA, Hur J, Feldman EL (2011) Stem cell technology for neurodegenerative diseases. Annu Neurol 70(3):353&#x2013;361</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>